Evidence map›Paper›PMID 38066173›Full record

ArticleEuropean journal of human genetics : EJHG2026

Correction: CDK13-related disorder: a deep characterization of speech and language abilities and addition of 33 novel cases.

Lottie D Morison, Olivia van Reyk, Elana Forbes, Flavien Rouxel, Laurence Faivre, Fiona Bruinsma, Marie Vincent, Marie-Line Jacquemont, Natalie L Dykzeul, David Geneviève and 2 more

Abstract readPublished Erratum
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Lottie D MorisonSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0003-2822-6522
Olivia van ReykSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-7333-4384
Elana ForbesSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Flavien RouxelGénétique Clinique, Départment de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CHU Montpellier, Montpellier University, Centre de Référence Anomalies du Développement SOOR, Montpellier, France.
Laurence FaivreCentre de Référence Anomalies du Développment et Syndromes Malformatifs, FHU TRANSLAD, CHU Dijon, Dijon, France.
Fiona BruinsmaCancer Council Victoria, Melbourne, VIC, Australia.
Marie VincentService de génétique médicale, CHU Nantes, 9 quai Moncousu, Nantes, France.ORCID http://orcid.org/0000-0003-1010-5618
Marie-Line JacquemontUnit of Medical Genetics, CHU La Réunion, Saint Pierre, France.
Natalie L DykzeulLucile Packard Children's Hospital, Stanford Children's Health, Palo Alto, CA, USA.
David GenevièveGénétique Clinique, Départment de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CHU Montpellier, Montpellier University, Centre de Référence Anomalies du Développement SOOR, Montpellier, France.ORCID http://orcid.org/0000-0001-6928-6287
David J AmorSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Angela T MorganSpeech and Language, Murdoch Children's Research Institute, Melbourne, VIC, Australia. angela.morgan@mcri.edu.au.ORCID http://orcid.org/0000-0003-1147-7405

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38066173
PMCPMC13247072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.